A Phase II Trial of Azacitidine (NSC-102816) and Gemtuzumab Ozogamicin (NSC-720568) As Induction and Post-Remission Therapy in Patients of Age 60 and Older with Previously Untreated Non-M3 Acute Myeloid Leukemia (SWOG S0703): Report On the Poor Risk Patients


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Nand, S; Othus, M; Godwin, JE; Willman, CL; Norwood, T; Erba, HP; Howard, D; Coutre, SE; Appelbaum, FR

Published Date

  • November 16, 2012

Published In

Volume / Issue

  • 120 / 21

Published By


  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)

Conference Location

  • Atlanta, GA

Conference Start Date

  • December 8, 2012

Conference End Date

  • December 11, 2012